Works by Takahiro Yano


Results: 34
    1
    2

    Mantle Cell Lymphoma: An Update.

    Published in:
    Leukemia & Lymphoma, 1992, v. 8, n. 3, p. 161, doi. 10.3109/10428199209054902
    By:
    • Raffeld, Mark;
    • Sander, Christian A.;
    • Yano, Takahiro;
    • Jaffe, Elaine S.
    Publication type:
    Article
    3
    4

    Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients.

    Published in:
    EJHaem, 2020, v. 1, n. 2, p. 507, doi. 10.1002/jha2.111
    By:
    • Yamasaki, Satoshi;
    • Kada, Akiko;
    • Choi, Ilseung;
    • Iida, Hiroatsu;
    • Sekiguchi, Naohiro;
    • Harada, Naoko;
    • Sawamura, Morio;
    • Shimomura, Takeshi;
    • Komeno, Takuya;
    • Yano, Takahiro;
    • Yoshida, Isao;
    • Yoshida, Shinichiro;
    • Sunami, Kazutaka;
    • Hishita, Terutoshi;
    • Takatsuki, Hiroshi;
    • Ohshima, Koichi;
    • Takeshita, Morishige;
    • Saito, Akiko M.;
    • Iwasaki, Hiromi;
    • Nagai, Hirokazu
    Publication type:
    Article
    5
    6
    7
    8

    Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.

    Published in:
    Cancer Science, 2012, v. 103, n. 2, p. 245, doi. 10.1111/j.1349-7006.2011.02139.x
    By:
    • Tomita, Naoto;
    • Yokoyama, Masahiro;
    • Yamamoto, Wataru;
    • Watanabe, Reina;
    • Shimazu, Yutaka;
    • Masaki, Yasufumi;
    • Tsunoda, Saburo;
    • Hashimoto, Chizuko;
    • Murayama, Kayoko;
    • Yano, Takahiro;
    • Okamoto, Rumiko;
    • Kikuchi, Ako;
    • Tamura, Kazuo;
    • Sato, Kazuya;
    • Sunami, Kazutaka;
    • Shibayama, Hirohiko;
    • Takimoto, Rishu;
    • Ohshima, Rika;
    • Hatta, Yoshihiro;
    • Moriuchi, Yukiyoshi
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups.

    Published in:
    International Journal of Hematology, 2013, v. 97, n. 1, p. 98, doi. 10.1007/s12185-012-1243-2
    By:
    • Kihara, Rika;
    • Watanabe, Tomoyuki;
    • Yano, Takahiro;
    • Uike, Naokuni;
    • Okamura, Seiichi;
    • Kawano, Fumio;
    • Hanada, Shuichi;
    • Sunami, Kazutaka;
    • Inoue, Nobumasa;
    • Sawamura, Morio;
    • Yoshida, Shin-ichiro;
    • Shimomura, Takeshi;
    • Kitano, Kiyoshi;
    • Kojima, Yuki;
    • Horibe, Keizo;
    • Nagai, Hirokazu
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30

    A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study.

    Published in:
    International Journal of Hematology, 2015, v. 101, n. 6, p. 554, doi. 10.1007/s12185-015-1767-3
    By:
    • Matsumoto, Kimihiro;
    • Takayama, Nobuyuki;
    • Aisa, Yoshinobu;
    • Ueno, Hironori;
    • Hagihara, Masao;
    • Watanabe, Kentaro;
    • Nakaya, Aya;
    • Chen, Kenko;
    • Shimizu, Takayuki;
    • Tsukada, Yuiko;
    • Yamada, Yuji;
    • Nakazato, Tomonori;
    • Ishida, Akaru;
    • Miyakawa, Yoshitaka;
    • Yokoyama, Kenji;
    • Nakajima, Hideaki;
    • Masuda, Yoshihiro;
    • Yano, Takahiro;
    • Okamoto, Shinichiro
    Publication type:
    Article
    31
    32

    The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 1, p. 97, doi. 10.1080/10428194.2017.1330541
    By:
    • Tomita, Naoto;
    • Yokoyama, Masahiro;
    • Yamamoto, Wataru;
    • Watanabe, Reina;
    • Shimazu, Yutaka;
    • Masaki, Yasufumi;
    • Tsunoda, Saburo;
    • Hashimoto, Chizuko;
    • Murayama, Kayoko;
    • Yano, Takahiro;
    • Okamoto, Rumiko;
    • Kikuchi, Ako;
    • Tamura, Kazuo;
    • Sato, Kazuya;
    • Sunami, Kazutaka;
    • Shibayama, Hirohiko;
    • Takimoto, Rishu;
    • Ohshima, Rika;
    • Takahashi, Hiromichi;
    • Moriuchi, Yukiyoshi
    Publication type:
    Article
    33

    Phase II study of intensified rituximab induction and maintenance for low grade B cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 12, p. 2845, doi. 10.1080/10428194.2017.1319054
    By:
    • Nagai, Hirokazu;
    • Shimomura, Takeshi;
    • Takeuchi, Makoto;
    • Hanada, Shuichi;
    • Komeno, Takuya;
    • Sunami, Kazutaka;
    • Hidaka, Michihiro;
    • Yano, Takahiro;
    • Kitano, Kiyoshi;
    • Yoshida, Isao;
    • Inoue, Nobumasa;
    • Saito, Akiko;
    • Horibe, Keizo;
    • Motitani, Suzuko;
    • Ichihara, Shu;
    • Watanabe, Tomoyuki;
    • Sawamura, Morio
    Publication type:
    Article
    34